Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 13, Number 5, 2007

Articles

Favourites:
ADD

NF-κB Signaling and Carcinogenesis
pp. 447-462(16)
Authors: Okamoto, Takashi; Sanda, Takaomi; Asamitsu, Kaori

Favourites:
ADD
Favourites:
ADD

Proteasome as an Emerging Therapeutic Target in Cancer
pp. 471-485(15)
Authors: Zavrski, I.; Kleeberg, L.; Kaiser, M.; Fleissner, C.; Heider, U.; Sterz, J.; Jakob, C.; Sezer, O.

Favourites:
ADD

Novel Therapeutic Approaches Based on the Targeting of Microenvironment-Derived Survival Pathways in Human Cancer: Experimental Models and Translational Issues
pp. 487-496(10)
Authors: Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Teresa Fulciniti, Maria; Teresa Di Martino, Maria; Venuta, Salvatore

Favourites:
ADD

Targeted Therapy of Breast Cancer
pp. 497-517(21)
Authors: Longo, Raffaele; Torino, Francesco; Gasparini, Giampietro

Favourites:
ADD

Current Concepts for the Combined Treatment Modality of Ionizing Radiation with Anticancer Agents
pp. 519-535(17)
Authors: Oehler, Christoph; Dickinson, Daniel J.; Broggini-Tenzer, Angela; Hofstetter, Barbara; Hollenstein, Andreas; Riesterer, Oliver; Vuong, Van; Pruschy, Martin

Favourites:
ADD

Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
pp. 537-551(15)
Authors: Mocellin, Simone; Pilati, Pierluigi; Nitti, Donato

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content